查看購物車
  • English
  • Japanese
全球胃腸支架市場：按產品、類型、應用、最終用戶和地區分類－預測至2031年
市場調查報告書
商品編碼
2059327

全球胃腸支架市場：按產品、類型、應用、最終用戶和地區分類－預測至2031年

Gastrointestinal Stent Market By Product (Duodenal, Pancreatic, Colonic, Biliary), Type [Metal (SEMS, Balloon-expandable, Nitinol, Stainless Steel), Plastic, Biodegradable], Application (Colorectal & Stomach Cancer), End User - Global Forecast to 2031
出版日期: | 出版商: MarketsandMarkets | 英文 432 Pages | 訂單完成後即時交付

價格

預計胃腸道支架市場規模將從 2026 年的 6.2 億美元成長到 2031 年的 8.2 億美元，複合年成長率為 5.7%。

推動這一成長的幾個關鍵因素塑造了胃腸道疾病微創治療、內視鏡治療和支架治療方案的未來。

調查範圍
調查期 2026-2031
基準年 2025
預測期 2026-2031
目標單元 金額（10億美元）
部分 按產品、類型、應用程式、最終用戶和地區分類。
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

胃腸道支架市場的主要驅動力是全球胃腸道疾病負擔的日益加重，例如癌症、狹窄和梗阻，以及人們對微創治療方法日益成長的偏好。隨著醫療系統致力於改善患者預後和縮短住院時間，臨床醫生擴大採用內視鏡介入治療，例如支架置入術，以有效管理複雜的胃腸道疾病。為此，醫院、專科診所和內視鏡中心正在擴大先進支架技術的應用，包括自膨式金屬支架（SEMS）、可生物分解支架和藥物釋放型。

胃腸道支架市場-IMG1

推動需求復甦的另一個關鍵因素是，人們越來越重視對慢性及惡性胃腸道疾病患者進行早期療育、安寧療護和改善生活品質。醫療專業人員和監管機構也致力於降低手術相關風險並提高臨床效率，促進了技術先進的支架解決方案的應用。因此，胃腸道支架已成為恢復通暢性、控制滲漏和瘻管以及支持術後復原的第一線治療方法，最終實現及時治療和更好的疾病管理效果。

此外，生物材料、支架設計和輸送系統的持續研發顯著提高了胃腸道支架的性能和安全性。諸如防移位功能、軟性低輪廓輸送系統、生物相容性塗層和可生物分解材料等創新技術有助於減少併發症並改善長期治療效果。這些技術進步使醫療專業人員能夠提高手術成功率，確保更穩定的患者療效，並將胃腸道支架的應用範圍擴展到更廣泛的臨床適應症。

“按產品細分市場來看，預計食道支架細分市場在預測期內將以最高的複合年成長率成長。”

受食道癌和良性狹窄發病率上升以及患者對快速緩解吞嚥困難的需求不斷成長的推動，食道支架預計將成為胃腸道支架市場中成長最快的細分市場。這些支架因其可透過微創手術立即恢復吞嚥功能而廣受歡迎，從而減少了對複雜手術的需求。此外，全覆膜設計、防移位功能和可生物分解選項等技術進步提高了安全性，並擴大了其在惡性和良性疾病中的應用範圍，進一步加速了其普及。

“按最終用戶分類，預計到 2025 年，醫院和診所領域將佔據最大的市場佔有率。”

到2025年，醫院和診所將主導胃腸道支架市場，因為它們是大多數內視鏡手術的主要施行地點。此外，這些機構通常擁有先進的基礎設施、專業的胃腸病學家以及支架置入所需的專用設備。它們也是治療複雜胃腸道疾病（例如癌症、狹窄和術後併發症）的主要中心，從而持續產生對支架相關手術的需求。此外，這些機構擁有更完善的保險報銷系統、更先進的技術以及處理緊急情況和高風險病例的能力，進一步鞏固了其市場主導地位。

“預計亞太地區在預測期內將呈現最高的成長率。”

亞太地區胃腸道支架市場成長速度最快。這一成長主要受胃腸道疾病和癌症發病率快速上升以及中國和印度等新興經濟體醫療設施擴張的推動。醫療保健投入的增加、微創治療意識的提高以及先進內視鏡治療的普及，都促進了該地區產品的市場應用。此外，龐大的患者群體、醫療設施投入的增加以及全球和區域醫療設備公司的進入，也共同推動了亞太地區市場的快速成長。

調查範圍

本市場研究報告涵蓋胃腸支架市場的各個細分領域，旨在按產品、類型、應用、最終用戶和地區評估該市場的規模和成長潛力。此外，該研究還包含市場主要參與者的詳細競爭分析，包括公司簡介、產品和業務概況、近期發展動態以及主要市場策略。

購買本報告的理由

本報告將幫助成熟企業和新興企業/中小企業了解市場趨勢，並擴大市場佔有率。獲得本報告的企業可以實施以下五項策略中的一項或多項。

本報告深入分析了以下幾點：

  • 影響胃腸道支架市場成長的因素分析，包括主要促進因素（胃腸道癌症和消化器官系統疾病（包括大腸直腸癌、食道癌和膽道疾病）發生率的增加；微創和內視鏡手術的廣泛應用）、阻礙因素（先進支架和內視鏡手術的高成本；發展中地區先進內視鏡基礎設施的匱乏）、機會（技術進步（可生物分解支架、藥物釋放型支架、LAMS）；對安寧療護和非手術治療方案的需求不斷成長）以及挑戰（嚴格的法規核准和臨床檢驗要求；資源匱乏地區熟練內視鏡醫師的短缺）。
  • 產品開發/創新：胃腸支架市場未來技術趨勢和新產品發布的詳細分析
  • 市場發展：提供新興盈利市場的全面資訊。本報告按地區分析了各種胃腸道支架產品的市場狀況。
  • 市場多元化：提供有關胃腸道支架市場的產品、未開發地區、近期趨勢和投資的全面資訊。
  • 競爭分析：對胃腸道支架市場主要參與者的市場佔有率、策略、產品、分銷網路和製造能力進行詳細評估。

目錄

第1章：引言

第2章執行摘要

第3章重要考察

第4章 市場概覽

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
    • 任務
  • 未滿足的需求和未開發的領域
  • 相互關聯的市場與跨產業機遇
  • 一級/二級/三級公司的策略性舉措

第5章 產業趨勢

  • 波特五力分析
  • 總體經濟指標
  • 價值鏈分析
  • 生態系分析
  • 價格分析
  • 貿易分析
  • 2026-2027 年主要會議和活動
  • 影響我們客戶公司業務的趨勢/變化
  • 投資和資金籌措場景
  • 成功案例和實際應用
  • 2025年美國關稅對胃腸支架市場的影響

第6章永續性和監管情勢

  • 當地法規和合規性
  • 對永續性的承諾

第7章：顧客趨勢與購買行為

  • 主要相關人員和採購標準
  • 客戶趨勢和購買行為

第8章：透過採用技術、專利、數位技術和人工智慧實現策略性顛覆性轉型

  • 技術分析
  • 技術/產品藍圖
  • 專利分析
  • 未來應用
  • 人工智慧/生成式人工智慧對胃腸道支架市場的影響

第9章：胃腸道支架市場（依產品分類）

  • 膽道支架
  • 食道支架
  • 結腸支架
  • 十二指腸支架
  • 胰管支架

第10章：胃腸道支架市場（按類型分類）

  • 金屬支架
  • 塑膠支架
  • 可生物分解支架

第11章：胃腸道支架市場（按應用領域分類）

  • 胃腸道癌症
  • 膽道疾病
  • 良性狹窄和滲漏
  • 其他

第12章：胃腸道支架市場（依最終用戶分類）

  • 醫院和診所
  • 專業內視鏡中心/胃腸病診所
  • 門診手術中心

第13章：胃腸道支架市場（按地區分類）

  • 北美洲
    • 北美宏觀經濟展望
    • 北美：胃腸道支架按類型分類的銷售量分析（2024-2031 年）（千件）
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 歐洲：可生物分解胃腸道支架銷售量分析（按類型分類，2024-2031 年，單位：千件）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區
    • 亞太地區宏觀經濟展望
    • 亞太地區：胃腸道支架銷售量分析（按類型分類，2024-2031 年，單位：千件）
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
    • 紐西蘭
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 拉丁美洲：胃腸道支架銷售量分析（按類型分類，2024-2031 年，單位：千件）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中東和非洲
    • 中東和非洲宏觀經濟展望
    • 中東和非洲：可生物分解胃腸道支架的定量分析（按類型，2024-2031 年）（單位：千）
    • 海灣合作理事會國家
    • 其他

第14章 競爭格局

  • 2023-2025年收入分析
  • 2025年市佔率分析
  • 企業估值矩陣：主要公司，2025 年
  • 公司估值矩陣：新創企業/中小企業，2025 年
  • 企業估值和財務指標
  • 產品/品牌對比
  • 競爭格局

第15章：公司簡介

  • 主要參與企業
    • BOSTON SCIENTIFIC CORPORATION
    • COOK MEDICAL
    • OLYMPUS CORPORATION
    • MI TECH
    • MICRO-TECH（NANJING）CO., LTD.
    • MERIT MEDICAL SYSTEMS
    • MEDTRONIC
    • ELLA-CS, SRO
    • STERIS
    • WL GORE & ASSOCIATES, INC.
    • BD
    • Q3 MEDICAL GROUP
    • MEDI-GLOBE GMBH
    • HOBBS MEDICAL INC.
    • BVM
  • 其他公司
    • LEUFEN
    • ALLIUM
    • MEDORAH MEDITEK PVT. LTD.
    • MITRA INDUSTRIES
    • ENDOGI MEDICAL
    • ADVIN HEALTH CARE
    • HUNAN FUDE TECHNOLOGY CO., LTD.
    • HOSPI LINE EQUIPMENTS PVT. LTD.
    • CITEC
    • G-FLEX

第16章調查方法

第17章附錄

Product Code: MD 5797

The gastrointestinal stent market is expected to grow from USD 0.62 billion in 2026 to USD 0.82 billion by 2031, at a CAGR of 5.7%. This growth is driven by several key factors shaping the future of minimally invasive gastrointestinal disease management, endoscopic interventions, and stent-based therapeutic solutions.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsBy Product, Type, Application, End User, Region
Regions coveredNorth America, Europe, APAC, LATAM, MEA

The gastrointestinal stent market is primarily driven by the rising global burden of gastrointestinal diseases, including cancers, strictures, and obstructions, as well as the growing preference for minimally invasive treatment approaches. As healthcare systems focus on improving patient outcomes and reducing hospital stays, clinicians are increasingly adopting endoscopic interventions, such as stent placement, to effectively manage complex GI conditions. In response, hospitals, specialty clinics, and endoscopy centers are increasingly using advanced stent technologies, such as self-expanding metal stents (SEMS), biodegradable stents, and drug-eluting stents, to enable precise treatment and rapid symptom relief for conditions including esophageal cancer, biliary obstruction, and colorectal strictures.

Gastrointestinal Stent Market - IMG1

Another important factor that will renew demand is the increasing focus on early intervention, palliative care, and enhancement of the quality of life of patients with chronic and malignant gastrointestinal diseases. Healthcare providers and regulatory bodies have also focused on reducing procedural risks and improving clinical efficiency, which has resulted in increasing use of technologically advanced stent solutions. As a result, GI stents have turned into a go-to treatment for restoring luminal patency, controlling leaks and fistulas, and assisting post-surgical recovery, which in turn facilitates timely treatment and better disease management outcomes.

Besides, ongoing research and development in biomaterials, stent design, and delivery systems have significantly improved the performance and safety of gastrointestinal stents. Innovations such as anti-migration features, flexible and low-profile delivery systems, biocompatible coatings, and biodegradable materials are helping reduce complications and improve long-term outcomes. With these technological advancements, healthcare providers can enhance procedural success rates, ensure more consistent patient outcomes, and expand the use of GI stents across a broader range of clinical indications.

"By product, the esophageal stents segment is projected to grow at the highest CAGR during the forecast period."

The esophageal stents segment is expected to see the highest growth in the gastrointestinal stent market due to the increasing prevalence of esophageal cancer and benign strictures, along with the high demand for rapid relief from dysphagia. These stents are widely preferred as they provide immediate restoration of swallowing function through minimally invasive procedures, reducing the need for complex surgeries. Additionally, advancements such as fully covered designs, anti-migration features, and biodegradable options have improved safety and expanded their use in both malignant and benign conditions, further accelerating their adoption.

"By end user, the hospitals and clinics segment accounted for the largest market share in 2025."

In 2025, the hospitals and clinics segment dominated the gastrointestinal stent market because it is the primary setting for most endoscopic procedures. Besides that, these places usually have the advanced infrastructure, expert gastroenterologists, and specialized equipment necessary for the installation of a stent. Moreover, they serve as the primary treatment for complex gastrointestinal conditions, such as cancers, strictures, and post-surgical complications, leading to a continuous demand for stent-based procedures. Additionally, they provide better reimbursement support, have access to more advanced technologies, and can manage emergency and high-risk cases, which makes their leading share in the market more conclusive.

"The Asia Pacific region is expected to witness the highest growth rate during the forecast period."

The Asia Pacific region is growing at the fastest rate in the gastrointestinal stent market. The main reason for this growth is mainly because of the swiftly rising incidence of gastrointestinal diseases and cancers, along with better healthcare facilities in emerging economies like China and India. Increasing funding for healthcare, enhancing awareness of less invasive procedures, and better accessibility to advanced endoscopic treatments are the factors encouraging the use of the products in the region. Besides that, a large patient pool, increased investments in healthcare centers, and the entry of global and regional medical device companies are contributing to the rapid growth of the market in the Asia Pacific.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
  • By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
  • By Region: North America (45%), Europe (15%), Asia Pacific (25%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

  • By End User: Hospitals & Clinics (54%), Ambulatory Surgical Centers (29%), and Specialty Endoscopy Centers/GI Clinics (17%)
  • By Designation: Gastroenterologists/Interventional Endoscopists (47%), General & GI Surgeons (22%), Heads/Directors of Gastroenterology Departments (15%), and Others (16%)
  • By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)

Research Coverage

The market study covers the gastrointestinal stent market in various segments. It aims to estimate the market size and growth potential of this market by product, type, application, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:

  • Analysis of key drivers (increasing incidence of gastrointestinal cancers and obstructive conditions, including colorectal, esophageal, and biliary disorders, increasing adoption of minimally invasive and endoscopic procedures), restraints (high cost of advanced stents and endoscopic procedures, limited access to advanced endoscopic infrastructure in developing regions), opportunities (technological advancements (biodegradable stents, drug-eluting stents, LAMS), increasing demand for palliative care and non-surgical treatment options), and challenges (stringent regulatory approvals and clinical validation requirements, lack of skilled endoscopists in low-resource settings) influencing the growth of the gastrointestinal stent market
  • Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the gastrointestinal stent market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of gastrointestinal stent products across regions
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the gastrointestinal stent market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the gastrointestinal stent market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 MARKET STAKEHOLDERS
  • 1.5 LIMITATIONS
  • 1.6 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN GASTROINTESTINAL STENTS MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 GASTROINTESTINAL STENTS MARKET OVERVIEW
  • 3.2 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE AND COUNTRY (2025)
  • 3.3 GASTROINTESTINAL STENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 3.4 GASTROINTESTINAL STENTS MARKET: REGIONAL MIX (2026-2031)
  • 3.5 GASTROINTESTINAL STENTS MARKET: DEVELOPED VS. DEVELOPING ECONOMIES

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rising burden of GI cancers and pancreaticobiliary diseases
      • 4.2.1.2 Growing preference for minimally invasive endoscopic palliation
      • 4.2.1.3 Technological advancements in GI stents
      • 4.2.1.4 Expanding use of SEMS over plastic stents
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 High device and procedure costs
      • 4.2.2.2 Risk of stent migration, perforation, bleeding, and re-obstruction
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Rising adoption in emerging markets
      • 4.2.3.2 Expansion of EUS-guided stenting procedures
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Need for high operator expertise
      • 4.2.4.2 Regulatory and post-market safety scrutiny
  • 4.3 UNMET NEEDS & WHITE SPACES
    • 4.3.1 UNMET NEEDS IN GASTROINTESTINAL STENTS MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
    • 4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF SUPPLIERS
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS & FORECAST
    • 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
    • 5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE TREND OF GASTROINTESTINAL STENTS, BY KEY PLAYER, 2023-2025
      • 5.5.1.1 Average selling price trend of gastrointestinal stents, by key player, 2023-2025
    • 5.5.2 AVERAGE SELLING PRICE TREND OF GASTROINTESTINAL STENTS, BY REGION, 2023-2025
      • 5.5.2.1 Average selling price trend of nitinol stents, by region, 2023-2025
      • 5.5.2.2 Average selling price trend of stainless-steel stents, by region, 2023-2025
      • 5.5.2.3 Average selling price trend of plastic stents, by region, 2023-2025
  • 5.6 TRADE ANALYSIS
    • 5.6.1 TRADE DATA FOR HS CODE 9018
      • 5.6.1.1 Import data for HS Code 9018
      • 5.6.1.2 Export data for HS Code 9018
    • 5.6.2 TRADE DATA FOR HS CODE 9021
      • 5.6.2.1 Import data for HS Code 9021
      • 5.6.2.2 Export data for HS Code 9021
  • 5.7 KEY CONFERENCES & EVENTS, 2026-2027
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.9 INVESTMENT & FUNDING SCENARIO
  • 5.10 SUCCESS STORIES & REAL-WORLD APPLICATIONS
    • 5.10.1 COLONIC STENTS FOR MALIGNANT COLORECTAL OBSTRUCTION
    • 5.10.2 DUODENAL STENTS FOR GASTRODUODENAL OUTLET OBSTRUCTION
    • 5.10.3 LARGE-CELL STENTS FOR MULTIPLE STENTING IN MALIGNANT HILAR BILIARY OBSTRUCTION
  • 5.11 IMPACT OF 2025 US TARIFFS ON GASTROINTESTINAL STENTS MARKET
    • 5.11.1 INTRODUCTION
    • 5.11.2 KEY TARIFF RATES
    • 5.11.3 PRICE IMPACT ANALYSIS
    • 5.11.4 IMPACT ON COUNTRY/REGION
    • 5.11.5 IMPACT ON END-USE INDUSTRIES
      • 5.11.5.1 Hospitals & clinics
      • 5.11.5.2 Specialty endoscopy centers/GI clinics
      • 5.11.5.3 Ambulatory surgical centers

6 SUSTAINABILITY & REGULATORY LANDSCAPE

  • 6.1 REGIONAL REGULATIONS & COMPLIANCE
    • 6.1.1 REGULATORY ANALYSIS
    • 6.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.1.3 INDUSTRY STANDARDS
  • 6.2 SUSTAINABILITY INITIATIVES
    • 6.2.1 RECYCLED & ECO-FRIENDLY MATERIALS FOR GASTROINTESTINAL STENTS
    • 6.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
    • 6.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 7.1 KEY STAKEHOLDERS & BUYING CRITERIA
    • 7.1.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 7.1.2 BUYING CRITERIA
  • 7.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
    • 7.2.1 DECISION-MAKING PROCESS
    • 7.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES
    • 7.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
    • 7.2.4 MARKET PROFITABILITY

8 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION

  • 8.1 TECHNOLOGY ANALYSIS
    • 8.1.1 KEY EMERGING TECHNOLOGIES
      • 8.1.1.1 Biodegradable gastrointestinal stents
      • 8.1.1.2 3D-printed personalized stents
    • 8.1.2 COMPLEMENTARY TECHNOLOGIES
      • 8.1.2.1 Advanced endoscopic imaging & AI-assisted endoscopy
      • 8.1.2.2 Minimally invasive surgical devices
    • 8.1.3 ADJACENT TECHNOLOGIES
      • 8.1.3.1 Surface modification technologies
      • 8.1.3.2 Nitinol alloy technology
  • 8.2 TECHNOLOGY/PRODUCT ROADMAP
    • 8.2.1 NEAR TERM (2025-2027)
    • 8.2.2 MID TERM (2028-2030)
    • 8.2.3 LONG TERM (2030+)
  • 8.3 PATENT ANALYSIS
    • 8.3.1 PATENT PUBLICATION TRENDS FOR GASTROINTESTINAL STENTS
    • 8.3.2 JURISDICTION & TOP APPLICANT ANALYSIS
  • 8.4 FUTURE APPLICATIONS
    • 8.4.1 AI-ASSISTED ENDOSCOPY & STENT PLACEMENT
    • 8.4.2 NEXT-GENERATION BIODEGRADABLE GI STENTS
    • 8.4.3 PERSONALIZED & 3D-PRINTED GI STENTS
    • 8.4.4 DRUG-ELUTING & SMART GI STENTS
    • 8.4.5 ROBOTIC-ASSISTED & IMAGE-GUIDED GI INTERVENTIONS
  • 8.5 IMPACT OF AI/GENERATIVE AI ON GASTROINTESTINAL STENTS MARKET
    • 8.5.1 INTRODUCTION
    • 8.5.2 MARKET POTENTIAL IN GASTROINTESTINAL STENTS ECOSYSTEM
    • 8.5.3 AI USE CASES
    • 8.5.4 KEY COMPANIES IMPLEMENTING AI IN GASTROINTESTINAL STENTS MARKET

9 GASTROINTESTINAL STENTS MARKET, BY PRODUCT

  • 9.1 INTRODUCTION
  • 9.2 BILIARY STENTS
    • 9.2.1 RISING BURDEN OF HEPATOBILIARY AND PANCREATIC DISORDERS TO BOOST DEMAND
  • 9.3 ESOPHAGEAL STENTS
    • 9.3.1 INCREASING ESOPHAGEAL CANCER INCIDENCE TO DRIVE MARKET
  • 9.4 COLONIC STENTS
    • 9.4.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE MANAGEMENT OF COLORECTAL OBSTRUCTIONS TO DRIVE MARKET
  • 9.5 DUODENAL STENTS
    • 9.5.1 EXPANDING USE OF ENDOSCOPIC PALLIATION TO FUEL MARKET GROWTH
  • 9.6 PANCREATIC STENTS
    • 9.6.1 RISING VOLUME OF ERCP PROCEDURES AND PANCREATIC DISEASE MANAGEMENT TO SUPPORT GROWTH

10 GASTROINTESTINAL STENTS MARKET, BY TYPE

  • 10.1 INTRODUCTION
  • 10.2 METAL STENTS
    • 10.2.1 METAL STENTS MARKET, BY TYPE
      • 10.2.1.1 Nitinol stents
        • 10.2.1.1.1 Growing demand for flexible and conformable stents to fuel demand
        • 10.2.1.1.2 Global volume analysis of nitinol stents, 2024-2031 (thousand units)
      • 10.2.1.2 Stainless steel stents
        • 10.2.1.2.1 Increasing need for high radial force solutions to support adoption
        • 10.2.1.2.2 Global volume analysis of stainless steel stents, 2024-2031 (thousand units)
      • 10.2.1.3 Other metal stents
    • 10.2.2 METAL STENTS MARKET, BY MECHANISM
      • 10.2.2.1 Self-expanding metal stents (SEMS)
        • 10.2.2.1.1 Expanding preference for minimally invasive cancer palliation to drive market growth
      • 10.2.2.2 Balloon-expandable metal stents (BEMS)
        • 10.2.2.2.1 Rising demand for precise stent deployment to support growth
    • 10.2.3 METAL STENTS MARKET, BY COVERAGE
      • 10.2.3.1 Uncovered stents
        • 10.2.3.1.1 Growing use in malignant biliary obstruction management to support adoption
      • 10.2.3.2 Fully covered stents
        • 10.2.3.2.1 Greater focus on preventing tissue ingrowth to fuel adoption
      • 10.2.3.3 Partially covered stents
        • 10.2.3.3.1 Increasing emphasis on balancing patency and migration control to boost demand
  • 10.3 PLASTIC STENTS
    • 10.3.1 INCREASING VOLUME OF TEMPORARY BILIARY AND PANCREATIC DRAINAGE PROCEDURES TO DRIVE DEMAND
    • 10.3.2 GLOBAL VOLUME ANALYSIS OF PLASTIC STENTS, 2024-2031 (THOUSAND UNITS)
  • 10.4 BIODEGRADABLE STENTS
    • 10.4.1 GLOBAL VOLUME ANALYSIS OF BIODEGRADABLE STENTS, 2024-2031 (THOUSAND UNITS)
    • 10.4.2 POLYMER-BASED BIODEGRADABLE STENTS
      • 10.4.2.1 Rising utilization in benign stricture treatment to support growth
    • 10.4.3 MAGNESIUM-BASED BIODEGRADABLE STENTS
      • 10.4.3.1 Advancements in bioresorbable metal technologies to drive market growth
    • 10.4.4 OTHER BIODEGRADABLE STENTS

11 GASTROINTESTINAL STENTS MARKET, BY APPLICATION

  • 11.1 INTRODUCTION
  • 11.2 GASTROINTESTINAL CANCER
    • 11.2.1 PANCREATIC CANCER
      • 11.2.1.1 Increasing pancreatic cancer burden to support growth
    • 11.2.2 COLORECTAL CANCER
      • 11.2.2.1 Rising colorectal cancer incidence to drive demand
    • 11.2.3 ESOPHAGEAL CANCER
      • 11.2.3.1 Growing need for dysphagia relief to accelerate esophageal stent adoption
    • 11.2.4 STOMACH CANCER
      • 11.2.4.1 Expanding use of minimally invasive palliation to boost market growth
  • 11.3 BILIARY DISEASE
    • 11.3.1 INCREASING PREVALENCE OF BILIARY OBSTRUCTIONS TO ACCELERATE MARKET GROWTH
  • 11.4 BENIGN STRICTURES & LEAKS
    • 11.4.1 GROWING ADOPTION OF ENDOSCOPIC MANAGEMENT OF BENIGN GI CONDITIONS TO FUEL MARKET GROWTH
  • 11.5 OTHER APPLICATIONS

12 GASTROINTESTINAL STENTS MARKET, BY END USER

  • 12.1 INTRODUCTION
  • 12.2 HOSPITALS & CLINICS
    • 12.2.1 RISING GASTROINTESTINAL CANCER BURDEN AND ADVANCED ENDOSCOPY CAPABILITIES TO DRIVE MARKET GROWTH
  • 12.3 SPECIALTY ENDOSCOPY CENTERS/GI CLINICS
    • 12.3.1 GROWING PREFERENCE FOR SPECIALIZED THERAPEUTIC ENDOSCOPY TO PROPEL MARKET
  • 12.4 AMBULATORY SURGICAL CENTERS
    • 12.4.1 SHIFT TOWARD OUTPATIENT MINIMALLY INVASIVE PROCEDURES TO FUEL GROWTH

13 GASTROINTESTINAL STENTS MARKET, BY REGION

  • 13.1 INTRODUCTION
  • 13.2 NORTH AMERICA
    • 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 13.2.2 NORTH AMERICA: VOLUME ANALYSIS OF GASTROINTESTINAL STENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
    • 13.2.3 US
      • 13.2.3.1 High GI disease burden and procedural volume to support adoption of GI stents
    • 13.2.4 CANADA
      • 13.2.4.1 Expanding minimally invasive GI interventions and aging demographics to drive market
  • 13.3 EUROPE
    • 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 13.3.2 EUROPE: VOLUME ANALYSIS OF BIODEGRADABLE GASTROINTESTINAL STENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
    • 13.3.3 GERMANY
      • 13.3.3.1 Germany to dominate European market
    • 13.3.4 UK
      • 13.3.4.1 Expanding NHS adoption of innovative devices to support market growth
    • 13.3.5 FRANCE
      • 13.3.5.1 Strong focus on advanced GI treatments and reimbursement coverage to boost adoption
    • 13.3.6 ITALY
      • 13.3.6.1 Growing preference for minimally invasive procedures to drive market penetration
    • 13.3.7 SPAIN
      • 13.3.7.1 Expanding endoscopy infrastructure to fuel gradual market growth
    • 13.3.8 NETHERLANDS
      • 13.3.8.1 Advanced gastroenterology services and increasing GI cancer burden to boost adoption
    • 13.3.9 SWEDEN
      • 13.3.9.1 High healthcare expenditure to fuel market growth
    • 13.3.10 POLAND
      • 13.3.10.1 Rising cancer incidence and modernization of endoscopy services to boost market
    • 13.3.11 REST OF EUROPE
  • 13.4 ASIA PACIFIC
    • 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 13.4.2 ASIA PACIFIC: VOLUME ANALYSIS OF GASTROINTESTINAL STENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
    • 13.4.3 CHINA
      • 13.4.3.1 China to dominate APAC market
    • 13.4.4 JAPAN
      • 13.4.4.1 Aging population and advanced endoscopy ecosystem to fuel market growth
    • 13.4.5 INDIA
      • 13.4.5.1 Growing cancer incidence and improving healthcare access to boost market growth
    • 13.4.6 AUSTRALIA
      • 13.4.6.1 Mature healthcare system and favorable regulatory pathways to enable early adoption
    • 13.4.7 SOUTH KOREA
      • 13.4.7.1 High screening rates and advanced clinical capabilities to boost market growth
    • 13.4.8 THAILAND
      • 13.4.8.1 Increasing colorectal and hepatobiliary cancer cases to support market growth
    • 13.4.9 NEW ZEALAND
      • 13.4.9.1 Expanding elderly population and strong cancer care services to boost demand
    • 13.4.10 REST OF ASIA PACIFIC
  • 13.5 LATIN AMERICA
    • 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 13.5.2 LATIN AMERICA: VOLUME ANALYSIS OF GASTROINTESTINAL STENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
    • 13.5.3 BRAZIL
      • 13.5.3.1 Large patient population and rising colorectal cancer cases to propel market demand
    • 13.5.4 MEXICO
      • 13.5.4.1 Growing endoscopy capacity and disease burden to support steady market growth
    • 13.5.5 ARGENTINA
      • 13.5.5.1 Increasing gastrointestinal cancer incidence and advanced clinical capabilities to drive growth
    • 13.5.6 REST OF LATIN AMERICA
  • 13.6 MIDDLE EAST & AFRICA
    • 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 13.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF BIODEGRADABLE GASTROINTESTINAL STENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
    • 13.6.3 GCC COUNTRIES
      • 13.6.3.1 Kingdom of Saudi Arabia (KSA)
        • 13.6.3.1.1 Healthcare transformation initiatives and rising cancer prevalence to fuel market expansion
      • 13.6.3.2 United Arab Emirates (UAE)
        • 13.6.3.2.1 Medical tourism growth and advanced healthcare investments to strengthen adoption
      • 13.6.3.3 Rest of GCC Countries
    • 13.6.4 REST OF MIDDLE EAST & AFRICA

14 COMPETITIVE LANDSCAPE

  • 14.1 INTRODUCTION
    • 14.1.1 KEY STRATEGIES ADOPTED BY PLAYERS IN GASTROINTESTINAL STENTS MARKET
  • 14.2 REVENUE ANALYSIS, 2023-2025
  • 14.3 MARKET SHARE ANALYSIS, 2025
    • 14.3.1 US GASTROINTESTINAL STENTS MARKET SHARE ANALYSIS, 2025
    • 14.3.2 EUROPE GASTROINTESTINAL STENTS MARKET SHARE ANALYSIS, 2025
  • 14.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 14.4.1 STARS
    • 14.4.2 EMERGING LEADERS
    • 14.4.3 PERVASIVE PLAYERS
    • 14.4.4 PARTICIPANTS
    • 14.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 14.4.5.1 Company footprint
      • 14.4.5.2 Region footprint
      • 14.4.5.3 Product footprint
      • 14.4.5.4 Type footprint
  • 14.5 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2025
    • 14.5.1 PROGRESSIVE COMPANIES
    • 14.5.2 RESPONSIVE COMPANIES
    • 14.5.3 DYNAMIC COMPANIES
    • 14.5.4 STARTING BLOCKS
    • 14.5.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2025
      • 14.5.5.1 Detailed list of key start-ups/SMEs
      • 14.5.5.2 Competitive benchmarking of start-ups/SMEs
  • 14.6 COMPANY VALUATION & FINANCIAL METRICS
    • 14.6.1 FINANCIAL METRICS
    • 14.6.2 COMPANY VALUATION
  • 14.7 PRODUCT/BRAND COMPARISON
  • 14.8 COMPETITIVE SCENARIO

15 COMPANY PROFILES

  • 15.1 KEY PLAYERS
    • 15.1.1 BOSTON SCIENTIFIC CORPORATION
      • 15.1.1.1 Business overview
      • 15.1.1.2 Products offered
      • 15.1.1.3 MnM view
        • 15.1.1.3.1 Right to win
        • 15.1.1.3.2 Strategic choices
        • 15.1.1.3.3 Weaknesses & competitive threats
    • 15.1.2 COOK MEDICAL
      • 15.1.2.1 Business overview
      • 15.1.2.2 Products offered
      • 15.1.2.3 Recent developments
        • 15.1.2.3.1 Other developments
      • 15.1.2.4 MnM view
        • 15.1.2.4.1 Right to win
        • 15.1.2.4.2 Strategic choices
        • 15.1.2.4.3 Weaknesses & competitive threats
    • 15.1.3 OLYMPUS CORPORATION
      • 15.1.3.1 Business overview
      • 15.1.3.2 Products offered
      • 15.1.3.3 Recent developments
        • 15.1.3.3.1 Deals
        • 15.1.3.3.2 Other developments
      • 15.1.3.4 MnM view
        • 15.1.3.4.1 Right to win
        • 15.1.3.4.2 Strategic choices
        • 15.1.3.4.3 Weaknesses & competitive threats
    • 15.1.4 M.I. TECH
      • 15.1.4.1 Business overview
      • 15.1.4.2 Products offered
      • 15.1.4.3 Recent developments
        • 15.1.4.3.1 Deals
      • 15.1.4.4 MnM view
        • 15.1.4.4.1 Right to win
        • 15.1.4.4.2 Strategic choices
        • 15.1.4.4.3 Weaknesses & competitive threats
    • 15.1.5 MICRO-TECH (NANJING) CO., LTD.
      • 15.1.5.1 Business overview
      • 15.1.5.2 Products offered
      • 15.1.5.3 Recent developments
        • 15.1.5.3.1 Deals
        • 15.1.5.3.2 Expansions
      • 15.1.5.4 MnM view
        • 15.1.5.4.1 Right to win
        • 15.1.5.4.2 Strategic choices
        • 15.1.5.4.3 Weaknesses & competitive threats
    • 15.1.6 MERIT MEDICAL SYSTEMS
      • 15.1.6.1 Business overview
      • 15.1.6.2 Products offered
      • 15.1.6.3 Recent developments
        • 15.1.6.3.1 Product launches & approvals
    • 15.1.7 MEDTRONIC
      • 15.1.7.1 Business overview
      • 15.1.7.2 Products offered
    • 15.1.8 ELLA-CS, S.R.O.
      • 15.1.8.1 Business overview
      • 15.1.8.2 Products offered
      • 15.1.8.3 Recent developments
        • 15.1.8.3.1 Product launches
        • 15.1.8.3.2 ther developments
    • 15.1.9 STERIS
      • 15.1.9.1 Business overview
      • 15.1.9.2 Products offered
    • 15.1.10 W. L. GORE & ASSOCIATES, INC.
      • 15.1.10.1 Business overview
      • 15.1.10.2 Products offered
      • 15.1.10.3 Recent developments
        • 15.1.10.3.1 Deals
    • 15.1.11 BD
      • 15.1.11.1 Business overview
      • 15.1.11.2 Products offered
    • 15.1.12 Q3 MEDICAL GROUP
      • 15.1.12.1 Business overview
      • 15.1.12.2 Products offered
      • 15.1.12.3 Recent developments
        • 15.1.12.3.1 Product approvals & enhancements
        • 15.1.12.3.2 Other developments
    • 15.1.13 MEDI-GLOBE GMBH
      • 15.1.13.1 Business overview
      • 15.1.13.2 Products offered
    • 15.1.14 HOBBS MEDICAL INC.
      • 15.1.14.1 Business overview
      • 15.1.14.2 Products offered
    • 15.1.15 BVM
      • 15.1.15.1 Business overview
      • 15.1.15.2 Products offered
  • 15.2 OTHER PLAYERS
    • 15.2.1 LEUFEN
    • 15.2.2 ALLIUM
    • 15.2.3 MEDORAH MEDITEK PVT. LTD.
    • 15.2.4 MITRA INDUSTRIES
    • 15.2.5 ENDOGI MEDICAL
    • 15.2.6 ADVIN HEALTH CARE
    • 15.2.7 HUNAN FUDE TECHNOLOGY CO., LTD.
    • 15.2.8 HOSPI LINE EQUIPMENTS PVT. LTD.
    • 15.2.9 CITEC
    • 15.2.10 G-FLEX

16 RESEARCH METHODOLOGY

  • 16.1 RESEARCH DATA
    • 16.1.1 SECONDARY DATA
      • 16.1.1.1 Key secondary sources
    • 16.1.2 PRIMARY DATA
    • 16.1.3 PRIMARY SOURCES
      • 16.1.3.1 Key data from primary sources
      • 16.1.3.2 Key industry insights
      • 16.1.3.3 Breakdown of primaries
  • 16.2 MARKET SIZE ESTIMATION
    • 16.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
    • 16.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
    • 16.2.3 APPROACH 3: TOP-DOWN APPROACH
    • 16.2.4 APPROACH 4: BOTTOM-UP APPROACH
    • 16.2.5 APPROACH 5: PRIMARY INTERVIEWS
    • 16.2.6 APPROACH 6: DEMAND-SIDE APPROACH
    • 16.2.7 APPROACH 7: VOLUME DATA ANALYSIS
  • 16.3 DATA TRIANGULATION & MARKET BREAKDOWN
  • 16.4 MARKET SHARE ASSESSMENT
  • 16.5 RESEARCH ASSUMPTIONS
    • 16.5.1 STUDY ASSUMPTIONS
    • 16.5.2 GROWTH RATE ASSUMPTIONS
  • 16.6 RISK ASSESSMENT
    • 16.6.1 RESEARCH LIMITATIONS

17 APPENDIX

  • 17.1 DISCUSSION GUIDE
  • 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.3 CUSTOMIZATION OPTIONS
    • 17.3.1 PRODUCT ANALYSIS
    • 17.3.2 COMPANY INFORMATION
    • 17.3.3 GEOGRAPHIC ANALYSIS
    • 17.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
    • 17.3.5 COUNTRY-LEVEL VOLUME ANALYSIS, BY PRODUCT
    • 17.3.6 MARKET SHARE ANALYSIS, BY PRODUCT (TOP 5 PLAYERS)
    • 17.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
  • 17.4 RELATED REPORTS
  • 17.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
  • TABLE 2 GASTROINTESTINAL STENTS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 3 GDP CHANGE, BY KEY COUNTRY, 2021-2030 (USD BILLION)
  • TABLE 4 AVERAGE SELLING PRICE TREND OF GASTROINTESTINAL STENTS, BY KEY PLAYER, 2023-2025
  • TABLE 5 AVERAGE SELLING PRICE TREND OF NITINOL STENTS, BY REGION, 2023-2025
  • TABLE 6 AVERAGE SELLING PRICE TREND OF STAINLESS-STEEL STENTS, BY REGION, 2023-2025
  • TABLE 7 AVERAGE SELLING PRICE TREND OF PLASTIC STENTS, BY REGION, 2023-2025
  • TABLE 8 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 9 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 10 IMPORT DATA FOR HS CODE 9021, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 11 EXPORT DATA FOR HS CODE 9021, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 12 GASTROINTESTINAL STENTS MARKET: MAJOR CONFERENCES & EVENTS IN 2026-2027
  • TABLE 13 CASE STUDY 1: COLONIC STENTS FOR MALIGNANT COLORECTAL OBSTRUCTION
  • TABLE 14 CASE STUDY 2: DUODENAL STENTS FOR GASTRODUODENAL OUTLET OBSTRUCTION
  • TABLE 15 CASE STUDY 3: LARGE-CELL STENTS FOR MULTIPLE STENTING IN MALIGNANT HILAR BILIARY OBSTRUCTION
  • TABLE 16 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 17 KEY PRODUCT-RELATED TARIFFS
  • TABLE 18 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
  • TABLE 19 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
  • TABLE 20 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
  • TABLE 21 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
  • TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 25 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROINTESTINAL STENTS
  • TABLE 27 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 28 KEY DIFFERENCES BETWEEN BIODEGRADABLE & NON-BIODEGRADABLE METAL STENTS
  • TABLE 29 GASTROINTESTINAL STENTS MARKET: MAJOR PATENTS
  • TABLE 30 KEY COMPANIES IMPLEMENTING AI IN GASTROINTESTINAL STENTS MARKET
  • TABLE 31 GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 32 GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024-2031(USD MILLION)
  • TABLE 33 KEY PLAYERS OFFERING BILIARY STENTS
  • TABLE 34 BILIARY STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 35 KEY PLAYERS PROVIDING ESOPHAGEAL STENTS
  • TABLE 36 ESOPHAGEAL STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 37 KEY PLAYERS PROVIDING COLONIC STENTS
  • TABLE 38 COLONIC STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 39 KEY PLAYERS PROVIDING DUODENAL STENTS
  • TABLE 40 DUODENAL STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 41 KEY PLAYERS PROVIDING PANCREATIC STENTS
  • TABLE 42 PANCREATIC STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 43 GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 44 KEY PLAYERS PROVIDING METAL STENTS
  • TABLE 45 METAL STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 46 METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 47 NITINOL STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 48 NITINOL STENTS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
  • TABLE 49 STAINLESS STEEL STENTS MARKET, BY COUNTRY, 2024-2031(USD MILLION)
  • TABLE 50 STAINLESS STEEL STENTS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
  • TABLE 51 OTHER METAL STENTS MARKET, BY COUNTRY, 2024-2031(USD MILLION)
  • TABLE 52 METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 53 SELF-EXPANDING METAL STENTS (SEMS) MARKET, BY COUNTRY, 2024-2031(USD MILLION)
  • TABLE 54 BALLOON-EXPANDABLE METAL STENTS (BEMS) MARKET, BY COUNTRY, 2024-2031(USD MILLION)
  • TABLE 55 METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 56 UNCOVERED STENTS MARKET, BY COUNTRY, 2024-2031(USD MILLION)
  • TABLE 57 FULLY COVERED STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 58 PARTIALLY COVERED STENTS MARKET, BY COUNTRY, 2024-2031(USD MILLION)
  • TABLE 59 KEY PLAYERS PROVIDING PLASTIC STENTS
  • TABLE 60 PLASTIC STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 61 PLASTIC STENTS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
  • TABLE 62 KEY PLAYERS PROVIDING BIODEGRADABLE STENTS
  • TABLE 63 BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 64 BIODEGRADABLE STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 65 BIODEGRADABLE STENTS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
  • TABLE 66 POLYMER-BASED BIODEGRADABLE STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 67 MAGNESIUM-BASED BIODEGRADABLE STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 68 OTHER BIODEGRADABLE STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 69 GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 70 GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 71 GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 72 GASTROINTESTINAL STENTS MARKET FOR PANCREATIC CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 73 GASTROINTESTINAL STENTS MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 74 GASTROINTESTINAL STENTS MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 75 GASTROINTESTINAL STENTS MARKET FOR STOMACH CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 76 GASTROINTESTINAL STENTS MARKET FOR BILIARY DISEASE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 77 GASTROINTESTINAL STENTS MARKET FOR BENIGN STRICTURES & LEAKS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 78 GASTROINTESTINAL STENTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 79 GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 80 GASTROINTESTINAL STENTS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 81 GASTROINTESTINAL STENTS MARKET FOR SPECIALTY ENDOSCOPY CENTERS/ GI CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 82 GASTROINTESTINAL STENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 83 GASTROINTESTINAL STENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 84 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 85 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 86 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 87 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 88 NORTH AMERICA: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 89 NORTH AMERICA: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 90 NORTH AMERICA: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 91 NORTH AMERICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 92 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 93 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 94 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 95 US: KEY MACROINDICATORS
  • TABLE 96 US: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 97 US: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 98 US: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 99 US: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 100 US: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 101 US: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 102 US: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 103 US: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 104 US: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 105 CANADA: KEY MACROINDICATORS
  • TABLE 106 CANADA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 107 CANADA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 108 CANADA: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 109 CANADA: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 110 CANADA: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 111 CANADA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 112 CANADA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 113 CANADA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 114 CANADA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 115 EUROPE: BIODEGRADABLE GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 116 EUROPE: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 117 EUROPE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 118 EUROPE: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 119 EUROPE: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 120 EUROPE: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 121 EUROPE: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 122 EUROPE: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 123 EUROPE: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 124 EUROPE: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 125 EUROPE: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 126 GERMANY: KEY MACROINDICATORS
  • TABLE 127 GERMANY: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 128 GERMANY: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 129 GERMANY: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 130 GERMANY: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 131 GERMANY: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 132 GERMANY: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 133 GERMANY: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 134 GERMANY: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 135 GERMANY: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 136 UK: KEY MACROINDICATORS
  • TABLE 137 UK: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 138 UK: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 139 UK: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 140 UK: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 141 UK: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 142 UK: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 143 UK: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 144 UK: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 145 UK: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 146 FRANCE: KEY MACROINDICATORS
  • TABLE 147 FRANCE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 148 FRANCE: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 149 FRANCE: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 150 FRANCE: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 151 FRANCE: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 152 FRANCE: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 153 FRANCE: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 154 FRANCE: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 155 FRANCE: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 156 ITALY: KEY MACROINDICATORS
  • TABLE 157 ITALY: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 158 ITALY: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 159 ITALY: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 160 ITALY: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 161 ITALY: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 162 ITALY: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 163 ITALY: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 164 ITALY: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 165 ITALY: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 166 SPAIN: KEY MACROINDICATORS
  • TABLE 167 SPAIN: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 168 SPAIN: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 169 SPAIN: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 170 SPAIN: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 171 SPAIN: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 172 SPAIN: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 173 SPAIN: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 174 SPAIN: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 175 SPAIN: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 176 NETHERLANDS: KEY MACROINDICATORS
  • TABLE 177 NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 178 NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 179 NETHERLANDS: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 180 NETHERLANDS: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 181 NETHERLANDS: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 182 NETHERLANDS: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 183 NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 184 NETHERLANDS: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 185 NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 186 SWEDEN: KEY MACROINDICATORS
  • TABLE 187 SWEDEN: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 188 SWEDEN: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 189 SWEDEN: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 190 SWEDEN: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 191 SWEDEN: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 192 SWEDEN: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 193 SWEDEN: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 194 SWEDEN: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 195 SWEDEN: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 196 POLAND: KEY MACROINDICATORS
  • TABLE 197 POLAND: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 198 POLAND: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 199 POLAND: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 200 POLAND: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 201 POLAND: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 202 POLAND: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 203 POLAND: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 204 POLAND: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 205 POLAND: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 206 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 207 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 208 REST OF EUROPE: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 209 REST OF EUROPE: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 210 REST OF EUROPE: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 211 REST OF EUROPE: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 212 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 213 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 214 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 215 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 216 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 218 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 220 ASIA PACIFIC: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 221 ASIA PACIFIC: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 222 ASIA PACIFIC: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 223 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 224 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 225 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 226 CHINA: KEY MACROINDICATORS
  • TABLE 227 CHINA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 228 CHINA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 229 CHINA: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 230 CHINA: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 231 CHINA: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 232 CHINA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 233 CHINA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 234 CHINA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 235 CHINA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 236 JAPAN: KEY MACROINDICATORS
  • TABLE 237 JAPAN: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 238 JAPAN: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 239 JAPAN: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 240 JAPAN: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 241 JAPAN: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 242 JAPAN: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 243 JAPAN: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 244 JAPAN: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 245 JAPAN: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 246 INDIA: KEY MACROINDICATORS
  • TABLE 247 INDIA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 248 INDIA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 249 INDIA: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 250 INDIA: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 251 INDIA: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 252 INDIA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 253 INDIA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 254 INDIA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 255 INDIA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 256 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 257 AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 258 AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 259 AUSTRALIA: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 260 AUSTRALIA: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 261 AUSTRALIA: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 262 AUSTRALIA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 263 AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 264 AUSTRALIA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 265 AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 266 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 267 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 268 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 269 SOUTH KOREA: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 270 SOUTH KOREA: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 271 SOUTH KOREA: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 272 SOUTH KOREA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 273 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 274 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 275 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 276 THAILAND: KEY MACROINDICATORS
  • TABLE 277 THAILAND: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 278 THAILAND: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 279 THAILAND: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 280 THAILAND: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 281 THAILAND: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 282 THAILAND: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 283 THAILAND: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 284 THAILAND: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 285 THAILAND: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 286 NEW ZEALAND: KEY MACROINDICATORS
  • TABLE 287 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 288 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 289 NEW ZEALAND: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 290 NEW ZEALAND: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 291 NEW ZEALAND: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 292 NEW ZEALAND: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 293 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 294 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 295 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 296 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 297 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 298 REST OF ASIA PACIFIC: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 299 REST OF ASIA PACIFIC: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 300 REST OF ASIA PACIFIC: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 301 REST OF ASIA PACIFIC: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 302 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 303 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 304 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 305 LATIN AMERICA: BIODEGRADABLE GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 306 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 307 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 308 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 309 LATIN AMERICA: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 310 LATIN AMERICA: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 311 LATIN AMERICA: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 312 LATIN AMERICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 313 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 314 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 315 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 316 BRAZIL: KEY MACROINDICATORS
  • TABLE 317 BRAZIL: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 318 BRAZIL: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 319 BRAZIL: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 320 BRAZIL: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 321 BRAZIL: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 322 BRAZIL: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 323 BRAZIL: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 324 BRAZIL: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 325 BRAZIL: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 326 MEXICO: KEY MACROINDICATORS
  • TABLE 327 MEXICO: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 328 MEXICO: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 329 MEXICO: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 330 MEXICO: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 331 MEXICO: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 332 MEXICO: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 333 MEXICO: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 334 MEXICO: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 335 MEXICO: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 336 ARGENTINA: KEY MACROINDICATORS
  • TABLE 337 ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 338 ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 339 ARGENTINA: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 340 ARGENTINA: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 341 ARGENTINA: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 342 ARGENTINA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 343 ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 344 ARGENTINA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 345 ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 346 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 347 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 348 REST OF LATIN AMERICA: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 349 REST OF LATIN AMERICA: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 350 REST OF LATIN AMERICA: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 351 REST OF LATIN AMERICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 352 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 353 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 354 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 355 MIDDLE EAST & AFRICA: BIODEGRADABLE GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 356 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 357 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 358 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 359 MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 360 MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 361 MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 362 MIDDLE EAST & AFRICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 363 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 364 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 365 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 366 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 367 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 368 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 369 GCC COUNTRIES: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 370 GCC COUNTRIES: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 371 GCC COUNTRIES: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 372 GCC COUNTRIES: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 373 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 374 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 375 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 376 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS
  • TABLE 377 KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 378 KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 379 KINGDOM OF SAUDI ARABIA: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 380 KINGDOM OF SAUDI ARABIA: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 381 KINGDOM OF SAUDI ARABIA: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 382 KINGDOM OF SAUDI ARABIA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 383 KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 384 KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 385 KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 386 UNITED ARAB EMIRATES: KEY MACROINDICATORS
  • TABLE 387 UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 388 UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 389 UNITED ARAB EMIRATES: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 390 UNITED ARAB EMIRATES: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 391 UNITED ARAB EMIRATES: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 392 UNITED ARAB EMIRATES: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 393 UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 394 UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 395 UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 396 REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 397 REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 398 REST OF GCC COUNTRIES: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 399 REST OF GCC COUNTRIES: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 400 REST OF GCC COUNTRIES: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 401 REST OF GCC COUNTRIES: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 402 REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 403 REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 404 REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 405 REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 406 REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 407 REST OF MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 408 REST OF MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY MECHANISM, 2024-2031 (USD MILLION)
  • TABLE 409 REST OF MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY COVERAGE, 2024-2031 (USD MILLION)
  • TABLE 410 REST OF MIDDLE EAST & AFRICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 411 REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 412 REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 413 REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 414 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN GASTROINTESTINAL STENTS MARKET
  • TABLE 415 GASTROINTESTINAL STENTS MARKET: DEGREE OF COMPETITION
  • TABLE 416 GASTROINTESTINAL STENTS MARKET: REGION FOOTPRINT
  • TABLE 417 GASTROINTESTINAL STENTS MARKET: PRODUCT FOOTPRINT
  • TABLE 418 GASTROINTESTINAL STENTS MARKET: TYPE FOOTPRINT
  • TABLE 419 GASTROINTESTINAL STENTS MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 420 GASTROINTESTINAL STENTS MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • TABLE 421 GASTROINTESTINAL STENTS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 422 GASTROINTESTINAL STENTS MARKET: DEALS, JANUARY 2022-MAY 2026
  • TABLE 423 GASTROINTESTINAL STENTS MARKET: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 424 GASTROINTESTINAL STENTS MARKET: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
  • TABLE 425 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 426 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 427 COOK MEDICAL: COMPANY OVERVIEW
  • TABLE 428 COOK MEDICAL: PRODUCTS OFFERED
  • TABLE 429 COOK MEDICAL: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
  • TABLE 430 OLYMPUS CORPORATION: COMPANY OVERVIEW
  • TABLE 431 OLYMPUS CORPORATION: PRODUCTS OFFERED
  • TABLE 432 OLYMPUS CORPORATION: DEALS, JANUARY 2023-MAY 2026
  • TABLE 433 OLYMPUS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
  • TABLE 434 M.I. TECH: COMPANY OVERVIEW
  • TABLE 435 M.I. TECH: PRODUCTS OFFERED
  • TABLE 436 M.I. TECH: DEALS, JANUARY 2022-MAY 2026
  • TABLE 437 MICRO-TECH (NANJING) CO., LTD.: COMPANY OVERVIEW
  • TABLE 438 MICRO-TECH (NANJING) CO., LTD.: PRODUCTS OFFERED
  • TABLE 439 MICRO-TECH (NANJING) CO., LTD.: DEALS, JANUARY 2022-MAY 2026
  • TABLE 440 MICRO-TECH (NANJING) CO., LTD.: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 441 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
  • TABLE 442 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
  • TABLE 443 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022- MAY 2026
  • TABLE 444 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 445 MEDTRONIC : PRODUCTS OFFERED
  • TABLE 446 ELLA-CS, S.R.O.: COMPANY OVERVIEW
  • TABLE 447 ELLA-CS, S.R.O.: PRODUCTS OFFERED
  • TABLE 448 ELLA-CS, S.R.O.: PRODUCT LAUNCHES, JANUARY 2022-MAY 2026
  • TABLE 449 ELLA-CS, S.R.O.: OTHER DEVELOPMENTS, JANUARY 2023-MAY 2026
  • TABLE 450 STERIS: COMPANY OVERVIEW
  • TABLE 451 STERIS: PRODUCTS OFFERED
  • TABLE 452 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW
  • TABLE 453 W. L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED
  • TABLE 454 W. L. GORE & ASSOCIATES, INC.: DEALS, JANUARY 2022-MAY 2026
  • TABLE 455 BD: COMPANY OVERVIEW
  • TABLE 456 BD: PRODUCTS OFFERED
  • TABLE 457 Q3 MEDICAL GROUP: COMPANY OVERVIEW
  • TABLE 458 Q3 MEDICAL GROUP: PRODUCTS OFFERED
  • TABLE 459 Q3 MEDICAL GROUP: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2023-MAY 2026
  • TABLE 460 Q3 MEDICAL GROUP: OTHER DEVELOPMENTS, JANUARY 2023-MAY 2026
  • TABLE 461 MEDI-GLOBE GMBH: COMPANY OVERVIEW
  • TABLE 462 MEDI-GLOBE GMBH: PRODUCTS OFFERED
  • TABLE 463 HOBBS MEDICAL INC.: COMPANY OVERVIEW
  • TABLE 464 HOBBS MEDICAL INC.: PRODUCTS OFFERED
  • TABLE 465 BVM: COMPANY OVERVIEW
  • TABLE 466 BVM: PRODUCTS OFFERED
  • TABLE 467 STUDY ASSUMPTIONS
  • TABLE 468 RISK ASSESSMENT ANALYSIS

List of Figures

  • FIGURE 1 GASTROINTESTINAL STENTS MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 MARKET SCENARIO
  • FIGURE 3 GLOBAL GASTROINTESTINAL STENTS MARKET, 2024-2031
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN GASTROINTESTINAL STENTS MARKET, 2023-2025
  • FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF GASTROINTESTINAL STENTS MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS IN GASTROINTESTINAL STENTS MARKET, 2026-2031
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN GASTROINTESTINAL STENTS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
  • FIGURE 8 STRONG FUTURE FOR MINIMALLY INVASIVE AND ADVANCED GASTROINTESTINAL INTERVENTIONS TO BOOST MARKET GROWTH
  • FIGURE 9 METAL STENTS AND CHINA DOMINATED MARKET IN 2025
  • FIGURE 10 APAC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 12 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 13 GASTROINTESTINAL STENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14 GASTROINTESTINAL STENTS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 15 GASTROINTESTINAL STENTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 16 GASTROINTESTINAL STENTS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 17 AVERAGE SELLING PRICE OF PLASTIC BILIARY STENTS, BY KEY PLAYER, 2025
  • FIGURE 18 AVERAGE SELLING PRICE OF GASTROINTESTINAL STENTS, BY REGION, 2025
  • FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 20 GASTROINTESTINAL STENTS MARKET: INVESTMENT & FUNDING SCENARIO
  • FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROINTESTINAL STENTS
  • FIGURE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 23 GASTROINTESTINAL STENTS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2015-MAY 2026)
  • FIGURE 24 TOP APPLICANT COUNTRIES/REGIONS FOR GASTROINTESTINAL STENT PATENTS (JANUARY 2015-MAY 2026)
  • FIGURE 25 AI USE CASES
  • FIGURE 26 GASTROINTESTINAL STENTS MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 27 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET SNAPSHOT
  • FIGURE 28 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET SNAPSHOT
  • FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN GASTROINTESTINAL STENTS MARKET (2023-2025)
  • FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN GASTROINTESTINAL STENTS MARKET, 2025
  • FIGURE 31 US GASTROINTESTINAL STENTS MARKET SHARE ANALYSIS, 2025
  • FIGURE 32 EUROPE GASTROINTESTINAL STENTS MARKET SHARE ANALYSIS, 2025
  • FIGURE 33 GASTROINTESTINAL STENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 34 GASTROINTESTINAL STENTS MARKET: COMPANY FOOTPRINT
  • FIGURE 35 GASTROINTESTINAL STENTS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2025
  • FIGURE 36 EV/EBITDA OF KEY VENDORS
  • FIGURE 37 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 38 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 39 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 40 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 41 M.I. TECH: COMPANY SNAPSHOT (2025)
  • FIGURE 42 MICRO-TECH (NANJING) CO., LTD.: COMPANY SNAPSHOT (2025)
  • FIGURE 43 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2025)
  • FIGURE 44 MEDTRONIC: COMPANY SNAPSHOT (2025)
  • FIGURE 45 STERIS: COMPANY SNAPSHOT (2025)
  • FIGURE 46 BD: COMPANY SNAPSHOT (2025)
  • FIGURE 47 GASTROINTESTINAL STENTS MARKET: RESEARCH DESIGN
  • FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 49 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 50 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 51 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 52 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 53 REVENUE SHARE ANALYSIS ILLUSTRATION: BOSTON SCIENTIFIC CORPORATION (2025)
  • FIGURE 54 TOP-DOWN APPROACH
  • FIGURE 55 BOTTOM-UP APPROACH
  • FIGURE 56 DEMAND-SIDE APPROACH
  • FIGURE 57 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GASTROINTESTINAL STENTS MARKET (2026-2031)
  • FIGURE 58 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 59 DATA TRIANGULATION METHODOLOGY